Article    Table of Contents                    Full Text of this article Free    Figures/Tables List    Related articles in Annals  Services    Send comment/rapid response letter    Notify a friend about this article    Alert me when this article is cited    Add to Personal Archive    Download to Citation Manager    ACP Search                            Get Permissions  Google Scholar    Search for Related Content  PubMed Articles in PubMed by Author:    Fonseca, R.    Gisvold, J. J.    Related Articles in PubMed    PubMed Citation    PubMed

REVIEW

Ductal Carcinoma in Situ of the Breast

Rafael Fonseca, MD; Lynn C. Hartmann, MD; Ivy A. Petersen, MD; John H. Donohue, MD; Thomas B. Crotty, MD; and John J. Gisvold, MD

1 December 1997 | Volume 127 Issue 11 | Pages 1013-1022

Purpose: The increasing incidence and biological heterogeneity of ductal carcinoma in situ (DCIS) of the breast have made the management of this entity challenging and controversial. This paper reviews data on the natural history of the disease and results obtained with various management approaches.

Data Sources: Computerized MEDLINE search of articles related to DCIS published since 1966.

Study Selection: Randomized trials were given higher value; however, because these were relatively scarce, retrospective studies and data published in abstract form were also included.

Data Extraction: The authors reviewed all sources critically. No formal statistical calculations were made.

Data Synthesis: The incidence of DCIS is increasing, and a greater proportion of diagnoses are being made in asymptomatic patients. No data from randomized trials compare mastectomy and breast-conserving therapy for the treatment of DCIS. A large randomized trial comparing lumpectomy with lumpectomy plus radiotherapy showed lumpectomy plus radiotherapy to be effective for management of this disease. The presence of comedo necrosis and surgical margin status are frequently used as predictors of subsequent recurrence, although this practice is controversial. The risk for in-breast recurrence at 5 years after lumpectomy and radiotherapy is approximately 8%. With more refined molecular analysis, the relation of DCIS to invasive breast cancer will be better defined.

Conclusions: Treatment strategies for DCIS have evolved, and lumpectomy followed by radiotherapy is an appropriate alternative for most patients. The use of lumpectomy alone in selected patients remains controversial.

Author and Article Information

From Mayo Clinic and Mayo Foundation, Rochester, Minnesota.
Requests for Reprints: Lynn C. Hartmann, MD, Mayo Clinic, 200 First Street SW, Rochester, MN 55905.
Current Author Addresses: Drs. Fonseca and Hartmann: Department of Medical Oncology, Mayo Clinic and Mayo Foundation, 200 First Street SW, Rochester, MN 55905.

Related articles in Annals:

Reviews
Using Autopsy Series To Estimate the Disease "Reservoir" for Ductal Carcinoma in Situ of the Breast: How Much More Breast Cancer Can We Find?
H. Gilbert Welch AND William C. Black

Annals 1997 127: 1023-1028. [ABSTRACT][Full Text]  

Perspectives
Lessons from the Mammography Screening Controversy: Can We Improve the Debate?
David F. Ransohoff AND Russell P. Harris

Annals 1997 127: 1029-1034. [ABSTRACT][Full Text]  

Articles
The Role of Numeracy in Understanding the Benefit of Screening Mammography
Lisa M. Schwartz, Steven Woloshin, William C. Black, AND H. Gilbert Welch

Annals 1997 127: 966-972. [ABSTRACT][Full Text]  

This article has been cited by other articles:

				V. L. Ernster, R. Ballard-Barbash, W. E. Barlow, Y. Zheng, D. L. Weaver, G. Cutter, B. C. Yankaskas, R. Rosenberg, P. A. Carney, K. Kerlikowske, et al. Detection of Ductal Carcinoma In Situ in Women Undergoing Screening Mammography J Natl Cancer Inst, October 16, 2002; 94(20): 1546 - 1554. [Abstract] [Full Text] [PDF]

				S. H. Taplin, C. M. Rutter, C. Finder, M. T. Mandelson, F. Houn, and E. White Screening Mammography: Clinical Image Quality and the Risk of Interval Breast Cancer Am. J. Roentgenol., April 1, 2002; 178(4): 797 - 803. [Abstract] [Full Text] [PDF]

				L. C. Walter and K. E. Covinsky Cancer Screening in Elderly Patients: A Framework for Individualized Decision Making JAMA, June 6, 2001; 285(21): 2750 - 2756. [Abstract] [Full Text] [PDF]

				M. H. Cohen, S. Hirschfeld, S. F. Honig, A. Ibrahim, J. R. Johnson, J. J. O'Leary, R. M. White, G. A. Williams, and R. Pazdur Drug Approval Summaries: Arsenic Trioxide, Tamoxifen Citrate, Anastrazole, Paclitaxel, Bexarotene Oncologist, February 1, 2001; 6(1): 4 - 11. [Abstract] [Full Text]

				L. Kopelovich, D. E. Henson, A. F. Gazdar, B. Dunn, S. Srivastava, G. J. Kelloff, and P. Greenwald Surrogate Anatomic/Functional Sites for Evaluating Cancer Risk: An Extension of the Field Effect Clin. Cancer Res., December 1, 1999; 5(12): 3899 - 3905. [Full Text] [PDF]

				M. B. Barton, R. Harris, and S. W. Fletcher Does This Patient Have Breast Cancer?: The Screening Clinical Breast Examination: Should It Be Done? How? JAMA, October 6, 1999; 282(13): 1270 - 1280. [Abstract] [Full Text] [PDF]

				L. C. Hartmann, D. J. Schaid, J. E. Woods, T. P. Crotty, J. L. Myers, P.G. Arnold, P. M. Petty, T. A. Sellers, J. L. Johnson, S. K. McDonnell, et al. Efficacy of Bilateral Prophylactic Mastectomy in Women with a Family History of Breast Cancer N. Engl. J. Med., January 14, 1999; 340(2): 77 - 84. [Abstract] [Full Text] [PDF]